AzTrials
AzTrials

Physical ActivityNCT02982967

Recreational Physical Activity and Cardiometabolic Profile

A study testing Physical Activity in people with Physical Activity and Endothelial Dysfunction, run by Federal University of São Paulo at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of present study was to investigate the effect of 10 weeks of recreational physical activity program on the irisin levels, progenitor endothelial cells and cardiometabolic profile in healthy children. Read more about this study

Who is it for?
Ages 6 to 14 yearsHealthy volunteers can take part
What is being tested?
Physical Activity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteBrazil
Study dates
Apr 2013to Jun 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 14 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Healthy Children
  • Both Gender
  • Aged 6 to 14 years

Who cannot join

  • Clinical signs of musculoskeletal or orthopedic disorders that prevented them from performing the proposed physical fitness tests.
  • Not completed anthropometric, metabolic or physical fitness assessments in the post-physical activity period

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Physiology Department - Federal University of são Paulo

    São Paulo, São Paulo, 04023-062

Other trials in Brazil

About this study

Official title: The Impact of the Recreational Physical Activity on Irisin Levels, Endothelial Progenitor Cells and Metabolic Profile in Healthy Children

The purpose of present study was to investigate the effect of 10 weeks of recreational physical activity program on the irisin levels, progenitor endothelial cells and cardiometabolic profile in healthy children. Also, we investigated the correlation between this markers with anthropometric data, body composition, cardiac autonomic balance and physical fitness parameters. We evaluated eighty children aged 6 to 14 participated in the recreational physical activity program by 10 weeks (Duration: 60 minutes; Intensity: 65%-85% heart rate reserve; Frequency: 4 sessions/week). All parameters were evaluated before and after this approach.

Read the detailed description

This cross-sectional study was conducted in a representative group of children aged 6 to 14 identified in the Youth Healthcare Centre located near the Federal University of São Paulo (São Paulo, SP, Brazil). A total of 110 children were identified during the study period. However, five individuals with respiratory problems and 12 individuals who did not agree to participate were excluded from the study. In addition, 13 individuals who have not completed anthropometric, metabolic or physical fitness assessments in the post-training period were also excluded. Therefore, 80 children (32 girls and 48 boys) were included for this study. No child had any clinical signs of musculoskeletal or orthopedic disorders that prevented them from performing the proposed physical fitness tests. The Ethics Committee of the Federal University of São Paulo approved the study protocol (Number: 795.262). All parents and children signed written informed consent/assent forms.

Experimental Design: Each child completed the experimental protocol over a period of 10 weeks consisting of the baseline measurements of anthropometric data, body composition, irisin levels, metabolic and physical fitness parameters. All these measurements were repeated after the 10-week recreational physical activity program and were carried out within 72 hours after the last training session.

Recreational Physical Activity Program: Participants performed 10 weeks of recreational physical activity program on circuit training, that consists of exercise program for flexibility, coordination, strength (upper and lower limbs), aerobic resistance controlled by use of the Polar S810i monitor (Polar Electro OY, Finland; sampling rate=100Hz) and dynamic balance to improve the functional capacity. A total of 40 sessions were performed with duration (60 minutes), intensity (65%-85% heart rate reserve), and frequency (4 sessions/week). Each session consisted of three parts: Warm-up (10 minutes), physical activity session (45 minutes) and cool down (5 minutes). Moreover, subjective Borg scale of perceived exertion was applied to all children for control of the training intensity.

Anthropometry: Body weight and height were measured in light clothing without shoes using a standard balance beam scale. Waist and hip circumferences were measured using inextensible tape. Waist circumference was recorded at a level midway between the lower rib margin and the iliac crest at the end of normal expiration. .

Body Composition: Body composition was evaluated using bioelectrical impedance with a single-frequency hand-to-foot (ImpediMed DF50 monitor, Impedimed, Australia). Children were asked to avoid physical activity and to consume liquids 2 hours before evaluation to prevent errors in measurement due to fluid imbalances. This evaluation was performed after 5 minutes of rest in the supine position, and the electrodes were applied to the hand, wrist, ankle and foot of the right-hand side of the body. Body fat was calculated with prediction equations.

Cardiorespiratory Fitness: The 20-meter shuttle run test (20MST) was performed to estimated cardiorespiratory fitness. The test starts at 8 km/h and increases by 0.5 km/h every minute. This test was carried out in a plane surface, and explained by the field team member. All children made adaptations to the 20MST test. The velocity in the last stage completed by each child was recorded and used to calculate the VO2max (ml/kg/min) according to the equation proposed by Léger et al.

Standing Broad Jump: The child stands behind a line marked on the ground. A two foot take-off and landing is used, with swinging of the arms, the child jumps as far as possible with both feet simultaneously. The test item score (better of three attempts) is the distance between the starting line and the landing position (measured in centimeters).

Sit and Reach Test: The flexibility was evaluated by use of the Wells Bench. For this test, the child performed the movement with hands overlapped, feet rested on the bench and knees totally extended with aid from the researcher. The result was given by the maximum distance obtained in three attempts, respecting a one-minute interval between them.

Handgrip Strength Test: Grip strength was measured for both hands using a digital dynamometer (Kern \& Sohn, Model MAP 80K1S, Germany). In this test, the child was seated in appropriately sized chairs, shoulder abducted, elbow in 90 degrees flexion, and wrist in neutral position. After that, the researcher asked the child to perform the greatest possible force in the shortest time. The mean of three maximum voluntary contractions was recorded for each hand and expressed in Kg.

Blood Collection and Biochemical Variables: In the morning (7:00 - 9: 00hrs) after overnight fasting, the blood venous samples (10 ml) were collected by venipuncture of a forearm vein into separate vacutainer tubes containing spray-dried K2EDTA anticoagulant or with gel serum separator. EDTA samples were centrifuged within 1 hour after blood collection (4°C - 1,500 g for 15 min) and plasma aliquots for irisin measurement were stored at -80°C until assay. Automated enzymatic procedures were used to measure glucose and insulin by routine methods in Clinical Laboratory of the Kidney \& Hypertension Hospital. Insulin resistance was calculated by the homeostasis model assessment (HOMA-IR) method, according to the following formula: [glucose (mg/dl)/18 x insulin (mUI/ml)]/22.5.

Assessment of Irisin: Plasma irisin levels were determined using commercially available ELISA kit (MyBioSource, Catalog Number: MBS 706887, San Diego, CA, USA). The intra assay and inter assay coefficients of variation were less than 8%. These assays were performed in duplicate, and to remove any bias, the researcher devised blind analysis techniques.

Hemodynamic Variables and Heart Rate Variability: Blood pressure levels were measured twice in the right arm with the child in a seated position using an automated oscillometric device (Omron HEM907XL; Omron Healthcare; USA) with an appropriate cuff size. The blood pressure value was the average of three measurements made at 2-min intervals . After this procedure, children were asked to lay silently in a supine position on a bed with minimal body movement and to maintain spontaneous breathing for 10 minutes to record both resting heart rate and short-term heart rate variability using a Polar S810i monitor (Polar Electro OY, Finland; sampling rate=100Hz) . The same researcher blinded to the clinical data conducted the assessment of all children.

Processing of the Heart Rate Variability Data: The heart rate variability indices were calculated as previously described 27, 28. Briefly, normal beat to beat intervals were transferred from Polar S810i to Precision Performance Software by an infrared interface device. These data were processed in a specific previous routine designed in MatLab (Math Works, 6.0 version, USA) for the automatic selection of 5 minutes RR with the smallest variance. Afterwards, these time series lasting 5 minutes were analyzed in Kubios software (Biosignal Analysis and Medical Image Group, University of Kuopio, Finland). In this software, the artifacts were corrected with a moderated filter, and the time-domain components were calculated. The following time-domain indices were analyzed: heart rate (HR), MNN (average of all normal RR interval), SDNN (standard deviation of RR intervals), RMSSD (root mean square of successive differences RR intervals), and pNN50 (percent RR intervals with a difference in duration higher than 50 ms). The frequency-domain components were also evaluated by a 2 power spectrum. The classical frequency low frequency (LF= 0.041-0.15 Hz) and high frequency (HF= 0.15-0.40 Hz) bands were expressed in normalized units (n.u.). Moreover, the ratio of LF/HF was also calculated. Spectral analysis was estimated as recommended using the non-parametric method of fast Fourier Transform Algorithms.

Isolation of Peripheral Blood Mononuclear Cells: In this assay 5-6 mL from peripheral blood were collected in EDTA tubes. Under sterile conditions, tibia and femur cavities were flushed with DMEM (Dulbecco's Modified Eagle's medium, GIBCO, USA) to obtain bone marrow (BM). PB and BM were fractioned by gradient density centrifugation (2.500 rpm, 25 min, 20-22°C) (Ficoll-Paque, GE, Germany), and then, mononuclear cells obtained from its samples were addressed to number quantification and in vitro function.

Endothelial progenitor cells Immunophenotyping and Quantification by Flow Cytometer: mononuclear cells was considered endothelial progenitor cells as CD34+/VEGFR2+ cells. Briefly, 1x106 mononuclear cells were individually incubated (room temperature, in the dark, 30 min) with the following antibodies: anti-CD34-PeCY7 plus VEGFR2-FITC or with isotype controls anti-IgG-PE-Cy7 plus IgG-FITC . After incubation, cells were washed in PBS and fixed in 1% paraformaldehyde solution. Fixed cells were kept (4°C, in the dark, for 15-20 hours), and then analyzed in flow cytometer (FACSCANTO, BD Biosciences, USA) by collecting 1.000.000 events. Data were analyzed using BD FACSDIVA Software . Gates were established on the forward- and side-scatter (FSC/SSC) plot corresponding to select mononuclear cells followed by CD34-PeCY7 plus VEGFR2-FITC gate . Number of EPCs (CD34+/VEGFR2+) was calculated as the percentage of CMNs events30.

Endothelial progenitor cells - Functional Capacity in vitro Assay: Mononuclear cells were individually addressed to colony forming unit in vitro. Briefly, 5x106 MNCs were cultured (37°C, 5% CO2, 95% humidity) on 6-wells pre-coated fibronectin seeded with EndoCult medium . After 48 hours, 1x106 non-adherent cells were transferred in triplicate onto 24-wells pre-coated fibronectin and cultured for 72-96 hours (37°C, 5% CO2, 95% humidity) in EndoCult medium. Following, the colony forming units were counted manually by 2 blinded observers in inverted microscope.

Statistical Analysis: Statistical analyses were conducted using SPSS version 21.0 for Windows (IBM Corporation, USA). Categorical variables were compared using the chi-square test. All continuous variables were examined for normality with the Shapiro-Wilk test. Since our data had a nonparametric distribution was used Wilcoxon test for paired data in order to evaluate the difference between the baseline and post-Recreational physical activity program values. In addition, we used Spearman's rho correlation coefficient to determine the relationship between irisin and independent factors. The data were expressed as the mean ± standard deviation. Statistical tests were two-tailed and the significance level was set at P<0.05.

Being tested
Physical Activity
Keywords
child, physical activity, irisin, EPCs
Medical subject headings
Motor Activity, Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical ActivityOther

    Recreational Physical Activity (Duration: 60 minutes; Intensity: 65%-85% heart rate reserve; Frequency: 4 sessions/week).

Study groups in NCT02982967
Study groupRoleWhat they receive
Physical ActivityOtherSingle-arm study with recreational physical activity intervention by 10 weeks (Duration: 60 minutes; Intensity: 65%-85% heart rate reserve; Frequency: 4 sessions/week).
Receives: Other: Physical Activity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. improvement in body composition

    Measured: 10 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Dec 2016 (estimated)
  2. Study startApr 2013
  3. Primary completionSep 2014
  4. Study completionJun 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02982967
Sponsor's protocol ID
2013/03139-0
Status last verified
Dec 2016
First submitted
2 Dec 2016
Last updated
6 Dec 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Souza LV, De Meneck F, Fernandes T, Oliveira EM, Franco MDC. Physical activity intervention improved the number and functionality of endothelial progenitor cells in low birth weight children. Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):60-70. doi: 10.1016/j.numecd.2019.08.011. Epub 2019 Aug 30.

    PubMed 31753788

Questions about this trial

What is this clinical trial studying?

A study testing Physical Activity in people with Physical Activity and Endothelial Dysfunction, run by Federal University of São Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

improvement in body composition (time frame: 10 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02982967, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in